![Maria Bedoya-Toro Munera](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 1 224 $ au 31/07/2026
Maria Bedoya-Toro Munera is currently Senior VP-Regulatory Affairs & Quality Assurance at Dermata Therapeutics, Inc. since 2016.
Former positions include Senior VP-Regulatory Affairs & Quality Assurance at Santarus, Inc. from 2011 to 2014, Senior VP-Regulatory Affairs & Quality Assurance at Receptos LLC from 2014 to 2015, Senior Director-Regulatory Affairs at Eisai Medical Research, Inc. from 2006 to 2007, Senior Director-Global Regulatory Affairs at Ligand Pharmaceuticals, Inc. from 2003 to 2006, Director-Global Regulatory Affairs at Baxter Hyland Immuno from 2000 to 2003, Director-Regulatory Affairs & Quality at BASF Bioresearch Corp.
from 1998 to 2000, and Director-Quality Assurance & Regulatory Compliance at Amylin Pharmaceuticals, Inc. from 1996 to 1998.
Education includes an MBA from The University of Chicago, a doctorate from The Ohio University, and undergraduate and graduate degrees from Western Michigan University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/02/2026 | 1 046 ( 0,04% ) | 1 224 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| DERMATA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/01/2016 |
| Sociétés | Poste | Fin |
|---|---|---|
| RECEPTOS INC | Conseiller Juridique Général | 01/01/2015 |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing and commercializing pharmaceutical products for the treatment of upper & lower gastrointestinal diseases and disorders | Conseiller Juridique Général | 02/01/2014 |
Eisai Medical Research, Inc. | Conseiller Juridique Général | 01/05/2007 |
| LIGAND PHARMACEUTICALS INCORPORATED | Conseiller Juridique Général | 01/01/2006 |
Baxter Hyland Immuno | Conseiller Juridique Général | 01/01/2003 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing and commercializing pharmaceutical products for the treatment of upper & lower gastrointestinal diseases and disorders | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Dermata Therapeutics, Inc.
 Dermata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which focusing on the treatment of medical and aesthetic skin conditions | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Michigan University
 Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eisai Medical Research, Inc. | Health Services |
Baxter Hyland Immuno | |
BASF Bioresearch Corp. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
